SCHEMBL15024564

SCHEMBL15024564

O=C1c2ccccc2C(=O)c2oc(/C(O)=C/[N+](=O)[O-])cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 5/20 0.56
ALDH1A1 P00352 4/20 0.56
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
STAT6 P42226 1/20 0.39
HIF1A Q16665 1/20 0.39
PHLPP2 Q6ZVD8 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PTPRC P08575 2/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
CES1 P23141 1/20 0.35
S100A4 P26447 1/20 0.35
BCL2 P10415 1/20 0.34
MCL1 Q07820 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18730820 0.81 STAT3 (0.69) STAT3ALDH1A1MAPK1BCL2MCL1
SCHEMBL18730837 0.78 STAT3 (0.60) STAT3ALDH1A1TP53CYP3A4MAPK1
SCHEMBL45742 0.77 STAT3 (0.58) STAT3ALDH1A1MAPK1BCL2MCL1
SCHEMBL45662 0.76 STAT3 (0.61) STAT3ALDH1A1MAPK1BCL2MCL1
SCHEMBL15006560 0.76 STAT3 (0.61) STAT3ALDH1A1MAPK1BCL2MCL1
SCHEMBL12640087 0.76 STAT3 (0.75) STAT3ALDH1A1PTPRCBCL2MCL1
Napabucasin SCHEMBL1883845 0.72 STAT3 (1.00) STAT3ALDH1A1MAPK1S100A4BCL2
Napabucasin SCHEMBL29349770 0.72 STAT3 (1.00) STAT3ALDH1A1MAPK1S100A4BCL2
SCHEMBL6001021 0.72 ALDH1A1 (0.69) STAT3ALDH1A1MAPK1HSD17B10KMT2A
SCHEMBL18691843 0.71 STAT3 (0.73) STAT3ALDH1A1MAPK1BCL2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871802-B2 Naphthoquinones for disease therapies ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2014-10-28 US disclosed
US-8871802-B2 Naphthoquinones for disease therapies ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2014-10-28 US disclosed
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2013-06-13 US disclosed
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO., LTD. (CN) 2013-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150437-A1 NAPHTHOQUINONES FOR DISEASE THERAPIES NQO1, NME2, CYP27B1 STAT3 1764/4885ALDH1A1 282/4885TP53 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.